Romania’s Competition Council is analyzing the transaction through which Medicover Investment BV intends to take over the Romanian companies belonging to Synlab International GmbH, namely, Synlab West SRL, Synlab Laboratories SRL, Zostalab SRL, Medsense Servicii Medicale SRL, CMI Dr Iacobescu C Anca SRL and CMI Dr Marinescu Dana Mihaela SRL.
Medicover Investment BV is part of the Medicover group, an international provider of medical and diagnostic services, which operates outpatient clinics, hospitals, specialist care facilities, laboratories and blood collection points in Poland, Germany, Romania, India and Ukraine.
In Romania, the Medicover Group operates through its healthcare services division, a network of 41 clinics and through its diagnostic services division, represented by Synevo Romania.
“In accordance with the provisions of Competition Law no. 21/1996, this operation must be authorized by the Competition Council, which will assess it in order to establish its compatibility with a normal competitive environment and will issue a decision within the legal deadlines,” the antitrust watchdog said in a press statement.